RecruitingPhase 1NCT06948136

Acute Effects of THC in Older Adult


Sponsor

Yale University

Enrollment

60 participants

Start Date

Jun 6, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The primary objective of this study is to determine if increasing age confers greater vulnerability to the acute A) cognitive (e.g., memory, attention, psychomotor function), B) subjective (e.g., anxiogenic and rewarding effects), and C) cardiovascular (heart rate and blood pressure), effects of THC in adults \> 21 years old. The secondary aims of the study are to explore age-related acute effects of THC on electrophysiological indices of information processing (e.g., auditory steady-state response (ASSR), oddball paradigm \[P300\], and resting state cortical noise) and to determine age-related differences in the metabolism of THC.


Eligibility

Min Age: 21 Years

Inclusion Criteria5

  • Ability to provide informed consent
  • No history (current or past) of unstable or serious medical, neurological or psychiatric conditions.
  • High school education or greater
  • No positive pregnancy test and/or lactation/ planning to nurse while in this study
  • English speaking

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGDelta-9-THC Low Dose

Active Delta-9-THC administered intravenously over 20 minutes.

DRUGPlacebo

Small amount of sterile ethanol (1-2 mLs), with no THC, administered intravenously over 20 minutes.

DRUGDelta-9-THC Medium Dose

Active Delta-9-THC administered intravenously over 20 minutes


Locations(1)

VA Connecticut Healthcare System

West Haven, Connecticut, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06948136


Related Trials